Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant
This study has been completed.
Sponsor:
Oslo University Hospital
Collaborators:
Bionor Immuno AS
Eurocine Vaccines AB
Information provided by (Responsible Party):
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01473810
First received: November 1, 2011
Last updated: June 19, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2012 |
| Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |